AI Bias Analysis
4 models · Takes ~15 seconds
(MedPage Today) -- For patients with moderate-to-severe deficits from an acute middle-vessel occlusion stroke, endovascular treatment within 24 hours of onset improved functional independence, the Chinese ORIENTAL-MeVO trial found. Survival without...
Source
MedPage Today
Opens original article in a new tab
(MedPage Today) -- The FDA granted accelerated approval to sonrotoclax (Beqalzi) as the first BCL2 inhibitor for relapsed or refractory mantle cell lymphoma (MCL), a rare and often aggressive subtype of non-Hodgkin lymphoma. A next-generation...
Despite rising concern about the hantavirus outbreak on a cruise ship, two CDC doctors say the risk to the public remains low.
(MedPage Today) -- Two patients taking the GLP-1 receptor agonist dulaglutide (Trulicity) developed choroidal lymphoid hyperplasia (CLH), a rare, benign condition of the uveal tract, that resolved after the patients stopped the drug. In both cases...
(MedPage Today) -- Patients with immunoglobulin A (IgA) nephropathy had less protein in their urine -- a key surrogate marker for the renal impairment caused by the condition -- after treatment with a dual-acting biologic agent that inhibits...
